Skip to content

Omnicell OMCL Amortization expense related to capitalized debt issuance costs

Amortization expense related to capitalized debt issuance costs at other companies

BrightSpring Health Services, Inc. logo
BrightSpring Health Services, Inc.BTSG
ICU Medical logo
ICU MedicalICUI
Medline, Inc.
 logo
Medline, Inc. MDLN
Astrana Health logo
Astrana HealthASTH

Other financials

Income statement

See full
Revenue$309.9M+14.9%
Gross profit$140.4M+26.5%
Operating income$16.9M+245%
Net income$11.4M+262%
EPS (diluted)$0.25+267%

Balance sheet

See full
Cash & equivalents$291.0M-29.8%
Total debt$34.3M-23.1%
Total equity$1.3B0.0%
Total assets$2.0B-6.8%

Cash flow

See full
Operating cash flow$54.5M+110%
CapEx$12.4M+11.3%
Free cash flow$42.1M+185%

Valuation

See full
Market cap$1.8B-7.2%
Enterprise value$1.54B-0.4%
P/E116.4×
P/S1.5×-0.2×

Profitability

See full
Gross margin43.5%+0.4pp
Operating margin2.7%+1.8pp
Net margin1.7%+1.1pp
FCF margin9.3%-1.7pp

Returns & leverage

See full
Return on equity1.6%+1.1pp
Debt / equity0.0×
Current ratio1.5×+0.1×

Where this comes from

Reported directly by Omnicell in its filing.

Tagged under the XBRL concept us-gaap:AmortizationOfFinancingCosts.

The official record: Omnicell’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Omnicell's amortization expense related to capitalized debt issuance costs.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Omnicell's amortization expense related to capitalized debt issuance costs?
Omnicell (OMCL) reported amortization expense related to capitalized debt issuance costs of $497K in Q1 2026.
How has Omnicell's amortization expense related to capitalized debt issuance costs changed year-over-year?
Omnicell's amortization expense related to capitalized debt issuance costs decreased by 32.4% year-over-year, from $735K to $497K.
What is the long-term trend for Omnicell's amortization expense related to capitalized debt issuance costs?
Over 4 years (2021 to 2025), Omnicell's amortization expense related to capitalized debt issuance costs has grown at a -6.3% compound annual growth rate (CAGR), from $3.44M to $2.65M.